Tirzepatide Sodium Overview

Tirzepatide Sodium is a synthetic peptide designed for laboratory investigation of dual receptor pathways involving glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). Due to its unique sequence and structure, Tirzepatide has gained significant interest in biochemical and metabolic research models focused on peptide-receptor interactions and metabolic regulation pathways.

Product Details

• Amino Acid Sequence: YE-Aib-GTFSDYSI-Aib-LDKIAQ (C20 fatty acid) AFVQWLIAGGPSSGAPPPS
• Note: Aib is a non-coded (non-proteinogenic) amino acid – H₂H-C(CH₃)₂-COOH
• Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
• Molecular Weight: 4813.527 g/mol
• PubChem CID: 156588324
• CAS Number: 2023788-19-2

Research Highlights

1. Incretin Pathway Research: Tirzepatide is studied for its role as a dual agonist of GIP and GLP-1 receptors, providing insight into glucose and lipid metabolism regulation under laboratory settings.
2. Peptide-Receptor Binding Studies: Its unique structure makes it a valuable candidate for receptor binding and pathway activation analysis in non-clinical models.

Usage and Safety Information

This product is intended for research purposes only. It is not approved for human or veterinary use. Proper safety protocols should be observed when handling Tirzepatide Sodium in laboratory environments.

Disclaimer

All content is for educational and scientific research use only. This material is not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption.